EMA (EU)
EVENT
Stakeholder Meeting on the transferable data exclusivity voucher (TDEV) for priority antimicrobials
Published: 11/12/2026Detected: 11/7/2026
Summary preview
Transferable data exclusivity vouchers (TEVs) for priority antimicrobials would allow extension of regulatory data protection by 12 months, either for the qualifying antimicrobial or for another product held by the same…
Get the full analysis, free
Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.
Create free accountinfectious_disease
manufacturing
quality
clinical
safety
labeling
#transferable data exclusivity voucher
#TEV
#data protection
#priority antimicrobial
#antimicrobial resistance
Official Source Document Source Verified
Access the original document directly from EMA.
More from EMA (EU)
- PMS Q&A Clinic on Product User Interface (PUI) and Application Programming Interface (API) – November 202611/12/2026
- Q&A clinic on eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) service - November 202611/12/2026
- HMA / EMA multistakeholder AI and Data forum: Build trustworthy AI on strong data foundations11/12/2026
- Q&A clinic on Substance, Organisation, Referentials Management Services - November 202611/11/2026
- Meeting of the Medicine Shortages Single Point of Contact (SPOC) Working Party11/10/2026